نتایج جستجو برای: acute leukemia

تعداد نتایج: 688128  

یزدانی چراتی, جمشید, خاکسار, شهربانو, موسوی نسب, سید نورالدین, کرمی, حسین,

Background and purpose: Acute leukemia is a malignancy with a rapidly progressive course of the lymphoid or myeloid cells. A prognostic factor for its survival and treatment is of particular importance in medical research. Therefore, this study aimed at applying competing risk model to compare clinical and pathologic factors in pediatric acute leukemia. Materials and methods: A historical coho...

Ansari Sh, Kiumarsi A, Rostami T,

Abnormalities of the thyroid gland are among the most frequent endocrine complications observed in childhood cancer survivors. We report an 11 years old girl who developed central hypothyroidism and ACTH deficiency during the chemotherapy for CNS relapse of acute lymphoblastic leukemia before receiving radiotherapy. Keywords: Thyroid gland, hypothyroidism, chemotherapy, acute lymphoblastic leu...

Journal: :iranian journal of public health 0
shadab shahriari maryam bakhshi ahmad reza shahverdi azar berahmeh farnaz safavifar mohammad reza khorramizadeh

abstract background: high temperatures have destructive effects on cancer cells by damaging proteins and structures within cells. gold nanoparticles (aunps) can act as drug delivery vehicles, especially for cancer therapy. due to the selective intake of asparagine molecules into malignant cells, aunps were coated with asparagine; and ccrf-cem human t-cell leukemia cells were treated with the ne...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: the traditional goal of the treatment of acute myelogenous leukemia is to produce and maintain a complete remission (cr).the difference in survival time was entirely attributable to the duration of time spent in cr .in this study, the outcome of aml patients with allogeneic hsct in cr1 versus other than cr1 was compared. patients and methods: since march 1991 until november 2008, ...

Journal: :international journal of hematology-oncology and stem cell research 0
a.r ardjmand correspondance: hematology, oncology & bmt research center, shariati hospital, kargar ave. 14114, tehran, iran k alimoghaddam hematology oncology & b.m.t research center, tehran university of medical science f zaker cellular & molecular research center, iran university of medical science a ghavamzadeh hematology oncology & b.m.t research center, tehran university of medical science m jahani hematology oncology & b.m.t research center, tehran university of medical science

background: acute promyelocytic leukemia is a sub-type of acute myelogenous leukemia that occurs in about 10-15% of patients with aml. approximately 20%-30% of these patients, who are treated with the current standard all trans retinoic acid (atra) and anthracyclin-based chemotherapy regimen, suffer relapse in less than a year. arsenic trioxide (ato) as a single agent can induce complete remiss...

Journal: :international journal of hematology-oncology and stem cell research 0
mahdi jalili hematology-oncology and sct research center, tehran university of medical sciences, tehran, iran ali salehzadeh-yazdi hematology-oncology and sct research center, tehran university of medical sciences, tehran, iran. department of systems biology and bioinformatics, university of rostock, rostock, germany. saeed mohammadi hematology-oncology and sct research center, tehran university of medical sciences, tehran, iran marjan yaghmaie hematology-oncology and sct research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology-oncology and sct research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and sct research center, tehran university of medical sciences, tehran, iran

background: acute promyelocytic leukemia (apl) is a unique subtype of acute leukemia. apl is a curable disease; however, drug resistance, early mortality, disease relapse and treatment-related complications remain challenges in apl patient management. one issue underlying these challenges is that the molecular mechanisms of the disease are not sufficiently understood. materials and methods: in ...

Journal: :international journal of pediatrics 0
hadi hayati department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran. abbas kebriaeezadeh department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran. mohammad ali ehsani department of pediatric hematology and oncology, bahrami hospital, tehran university of medical sciences, tehran, ir iran. shekoufeh nikfar department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, ir iran. azim mehrvar mahak pediatric cancer treatment and research center, tehran, ir iran.

background among all pediatric cancers acute lymphoblastic leukemia (all) is highly prevalent, butthe overall cost of all management is not well-known, there is a need to assess the berlin-frankfurt-munster (bfm) protocol commonly used in all management in iran. so, the aim of this study was to estimate direct and indirect costs of all treatment among children based on the all-bfm protocol from...

Journal: :reports of biochemistry and molecular biology 0
saeedeh ghazaey zidanloo department of molecular and cell biology, faculty of basic sciences, university of mazandaran, babolsar, cp: 47416-95447, iran abasalt hosseinzaeh colagar tel: +98 1125342452; fax: +98 1125342452

background: the human aml1 gene, located on chromosome 21, can be fused to the aml1- eight-twenty-one (eto) oncoprotein on chromosome eight, resulting in a t(8;21)(q22;q22) translocation. acute myeloid leukemia (aml) associated with this translocation is considered a distinct aml with a favorable prognosis. due to the various incidences of the translocation, which is associated with geographic ...

Journal: :iranian journal of pediatric hematology and oncology 0
ح فرهنگی h farhangi assistant professor of pediatric hematology & oncology, faculty of medicine, mashhad university of medical sciences, mas ز بدیعی z badiei associated professor of pediatric hematology & oncology, faculty of medicine, mashhad university of medical sciences, mسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) ف موهرری f moharreri psychiatry and behavioral sciences research center, ibn-e-sina hospital, faculty of medicine, mashhad university of mediسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

abstract background cancer diagnosis may cause deep emotional and affective problems in patients and their families.nowadays, however, despite its rising prevalence,cancer is no longer synonymous with death. given the significance of emotional well-being in cancer patients, we decided to assess the frequency of psychological problems in seven to seventeen yearolds with acute lymphoblastic leuke...

Journal: :iranian journal of pediatric hematology and oncology 0
m dorchin radiation oncologist, oncology department, dezfol university of medical sciences. dezfol. iran. 2. hematooncologist, oncسازمان های دیگر: hematooncologist, oncology department, al-bairouni university hospital, medical faculty, damascus university, damascus, syria. r masoumi dehshiri health policy research center, shahid sadoughi university of medical sciences and health services, yazd, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی دزفول (dezful university of medical sciences) s soleiman hematooncologist, oncology department, al-bairouni university hospital, medical faculty, damascus university, damascus,سازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) m manashi hematooncologist, oncology department, al-bairouni university hospital, medical faculty, damascus university, damascus,سازمان اصلی تایید شده: 0 دانشگاه های خارج از کشور

back ground: vincristine (vcr), is a chemotherapy drug, useful in the treatment of leukemia, lymphoma and solid tumor and it is a potent neurotoxin and sensory neuropathy drug which a common behavioral toxicity of this drug. neuropathy is common squeal of intensive chemotherapy protocols that contain vincristine and corticosteroids. materials and methods: this study was a retrospective and desc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید